|Publication number||US4534758 A|
|Application number||US 06/514,268|
|Publication date||Aug 13, 1985|
|Filing date||Jul 15, 1983|
|Priority date||Jul 15, 1983|
|Publication number||06514268, 514268, US 4534758 A, US 4534758A, US-A-4534758, US4534758 A, US4534758A|
|Inventors||Michael J. Akers, William W. Hargrove, Dale C. Harris, Charles R. Sperry|
|Original Assignee||Eli Lilly & Company|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (25), Referenced by (141), Classifications (15), Legal Events (6)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This invention relates generally to systems for intravenously administering medicine to a patient and more particularly to a system for reconstituting a drug from a dried state to a liquid state while the drug is still within the conventional drug-containing vial and thereafter administering the reconstituted drug by means of a primary intravenous administration set into which the drug vial is serially connected by means of a valve adaptor.
Conventional medical treatment frequently requires the intravenous administration of fluids and medicated solutions. Such fluids can include saline and dextrose solutions as well as other solutions to correct imbalances in body chemistry and medication solutions to treat disease. Many such solutions are frequently available in commercial antiseptic solution containers that are adapted to be punctured at one end and to be hung by the other end so that their liquid contents may be removed and infused in a vein of a patient by means of primary intravenous administration set, commonly referred to as an I.V. set.
In effecting such treatment, the closure of the solution container is punctured by a spike on the upper end of the delivery tube or conduit of the I.V. set so as to conduct the liquid material from the solution to a hypodermic needle or butterfly situated for injection into a vein of the patient.
Such I.V. sets generally also include a transparent drip chamber which includes the conduit-forming spike at the upper end which is intended to perforate and enter the solution container. The transparent drip chamber is generally employed as a means to measure the administration rate of the fluid to the patient, the rate typically being measured in drips per minute. A transparent flexible plastic tube is generally attached to the lower end of the drip chamber and a regulating clamp is provided as means to control the flow of liquid through the passageway of the plastic tube. One or more Y injection sights can be provided to attach other medicament dispensers. The I.V. set may also include a peristaltic pump to control the rate of delivery of fluid to the patient as well as a particle filter and air eliminator to insure that no air or small particles of medicine or foreign matter enter into the vein of the patient. Generally the use of conventional I.V. sets requires aseptic techniques and the I.V. set is protected against contamination during handling at the point of attachments by appropriate protective end caps and the like.
Certain of the medicines which are desirably administered to a patient by an intravenous administration set are manufactured and packaged in dry form due principally to their instability in liquid solution. The drug in dry form is typically commercially delivered in a standard glass vial containing one or two grams of the medication. The glass vial is closed with a rubber stopper and crimped aluminum seal, the aluminum seal usually having a flip off plastic cover intended to keep the top of the rubber stopper clean and to provide a means of tamper evidence. The glass vial itself is generally sized to accommodate about 10 to 15 cubic centimeters.
To reconstitute the dried drug compound, the general practice in the prior art was to remove the plastic seal exposing the rubber stopper and, after wiping the stopper with an aseptic wipe, adding five to ten cc's of sterile water diluent by inserting the needle of a syringe through the rubber stopper and depositing the contents of the syringe into the vial. One would then shake the vial to make sure the drug compound within the vial was fully dissolved or suspended in the diluent to form a reconstituted drug solution. This reconstituted solution was then withdrawn from the vial by means of a syringe, the needle of which was again inserted through the rubber stopper. The reconstituted solution was then typically injected into a plastic or glass container which had been previously filled with 50 or 100 cc's of a compatible I.V. diluent such as sterile water with a small percentage of dextrose of sodium chloride added. This container containing the fully diluted drug was then attached to the I.V. administration set with a separate drip chamber usually at a Y site and hung slightly above the primary I.V. source container.
If the reconstituted drug was not intended for immediate use, it was generally stored under a refrigerated condition until such time as the patient was ready for its administration. Once a drug compound has been reconstituted, however, a degradation of the compound begins. Refrigeration will slow this process but it is generally accepted practice to administer the reconstituted drug within a few hours, or at most one or two days so as to prevent any substantial degradation of the drug compound. Due to many influences such as patient reactions to the drug, patient recoveries, and the like, substantial percentages of the reconstitued drugs are not used within the acceptable time limits and must be discarded. Some of the drug compound itself is lost during the reconstitution steps as it is difficult to remove all of the reconstituted solution from the original drug containing vial by means of the syringe and needle. For this reason, the general commercial practice is to over fill the vials by approximately 7%. Other losses of the drug occur as the fully reconstituted container empties into the Y site through a drip chamber, some of the drug remains undelivered in the drip chamber. All of these losses tend to increase the cost of drugs to the ultimate purchaser, whether that be the patient or an insurance company.
The present invention provides a system for the administration of medicines which are typically packaged in standard small glass vials by providing a valve adaptor to a primary intravenous administration set which adaptor serially connects the drug containing vial directly to the primary delivery tube of the I.V. set in such a fashion as to permit administration of the contents of the vial to the patient. The valve adaptor includes means operable to a first and a second position providing for the dilution of the contents of the vial in the first position with liquid from the primary I.V. solution container, and after the drug is resuspended within the vial, the valve means permits delivery of the diluted contents of the vial in the second position directly to the primary I.V. passageway.
The invention has the advantage of permiting the use of the conventional glass vial as the mixing and dispensing chamber for the drug thereby reducing the chance of contamination of the drug and minimizing exposure of hospital personnel to the compound. This use of the conventional small drug containing vial as the mixing and delivery chamber after connection with the primary I.V. set eliminates any separate reconstitution in a hospital pharmacy, and the consequent need for refrigeration, and reduces storage space requirements. The invention also has been found to deliver an increased quantity of the drug in question, thereby substantially eliminating the need for the 7% over fill typically practiced in the industry. This system is intended to permit the administration of different medicines at scheduled intervals and can be used with most standard I.V. system components.
Additional features and advantages of the invention will become apparent to those skilled in the art upon consideration of the following detailed description of prefered embodiments exemplifying the best mode of carrying out the invention as presently preceived. The detailed description particularly refers to the accompanying figures in which:
FIG. 1 is a schematic illustration of a primary I.V. administration set including a valved adaptor of the present invention.
FIG. 2 is a view similar to that of FIG. 1 including a primary liquid container.
FIG. 3 is a view similar to FIG. 2 showing the addition of a conventional drug containing vial to the valved adaptor.
FIG. 4 is a view similar to FIG. 3 showing the valved adaptor and drug containing vial in the dispensing position.
FIG. 5 is a sectional view of one embodiment of the valved adaptor shown in the upright position.
FIG. 6 is a view of the valved adaptor shown in FIG. 5 in its inverted drug delivery position.
FIG. 7 is a sectional view of another embodiment of the valved adaptor shown in the upright position.
FIG. 8 is a sectional view of the valved adaptor shown in FIG. 7 in the inverted drug delivery position.
FIG. 9 is a sectional view of yet another embodiment of a valve adaptor shown in the upright bypass position.
FIG. 10 is a sectional view of the valved adaptor in FIG. 9 shown in the upright vent and fill position.
FIG. 11 is a sectional view of the valved adaptor shown in FIG. 9 in the inverted drug administering position.
FIG. 12 is a sectional view of yet another embodiment of a valved adaptor according to the present invention.
FIG. 13 is a side elevation view of yet another embodiment of a valved adaptor according to the present invention.
FIG. 14 is a sectional view of the valved adaptor shown in FIG. 13 with the valve situated in the bypass position.
FIG. 15 is yet another sectional view of the valve adaptor shown in FIG. 13 in the fill position.
FIG. 16 is yet another sectional view of the valved adaptor shown in FIG. 13 in the inverted drug delivery position.
The system 10 of this invention is shown schematically in FIGS. 1 through 4 to include a container 12 containing a source of liquid for delivery to a patient, not illustrated. The source of liquid 12 can be any conventionally employed source such as the type manufactured by Travenol Laboratories, Inc., of Deerfield, Ill., 60015, and sold under the registered trademark VIAFLEX as a single dose container. Generally such containers are clear and include means 13 for suspending the container above the patient. A drip chamber 14 generally included with a conventional I.V. set includes a spike 16 adapted to perforate and enter closure 15 on the lower end of container 12. Prior to its insertion into the closure 15, the spike 16 is protected by cover 17 so as to prevent contamination of the spike and conduit within the spike. The drip chamber 14 is formed from transparent material, typically plastic to permit visual monitoring of the rate at which liquid is being administered to the patient. The lower end 18 of the drip chamber is connected to a conduit 19 typically formed of a transparent flexible plastic tube intended to carry the liquid from the drip chamber 14 to the patient. One or more Y injection sites 20 can be provided for the connection of additional sources of fluids and medicines to the system. The Y injection sites provide a sterile access to the passageway within the tubing 19. Each Y injection site 20 is closed by a standard rubber stopper adapted to receive a hypodermic needle or the like in a sterile fashion. A luer needle adaptor 21 is provided at the lower end of the I.V. system. The adaptor permits the connection of the lower end of the I.V. tubing to a hypodermic needle inserted in a vein of the patient. The lower end of the needle adaptor 21 is typically protected by a cover 22 until the system is ready for use. A clamp 23 is provided at some point along the tubing 19 for regulating the flow through the tubing. The clamp 23 includes a serrated roller 24 which engages the outer surface of the flexible plastic tube 19 to pinch the tube to a desired degree thereby imposing a restriction upon the size of the passageway within the tubing and hence controlling the rate at which liquid from the container 12 passes through the tubing 19. A conventional particle/air filter 25 such as a Model 2C0251 available from Travenol Laboratories can also be included for preventing air or particles of medicine or foreign matter from entering the lower portion of the I.V. system. All of the components previously mentioned are conventionally available and except the particle/air filter 25 are distributed by Ivac Corporation of San Diego, Calif. 92121.
In accordance with the present invention, a valved adaptor 26 is connected to the previously described portions of the primary I.V. administration set by two short lengths of tubing 27 and 28. The lower end of the valved adaptor includes a spike 29 protected until use with a cover 30. The valved adaptor 26 is designed such that when not in use as shown in FIG. 2, liquid from the container 12 passes through drip chamber 14 down short tubing segment 27 through the valved adaptor 26 and back up short tubing section 28 to the remaining portion of the I.V. administration set. The rate of delivery of liquid from the container 12 to the patient can be adjusted by clamp 23 while visually inspecting the drip rate in drip chamber 14 in the conventional fashion.
At such time as one desires to administer a drug by way of the primary I.V. administration set shown, the cover 30 is removed exposing spike 29. The spike 29 is then forced through the rubber stopper of a conventional drug containing glass vial to the position shown in FIG. 3. The valved adaptor is then manually actuated by means of a valve push button 31 which causes liquid from container 12 to enter the drug containing vial 32. As the fluid from container 12 enters vial 32, the valve 26 also permits air to escape from the vial 32. The amount of liquid delivered to the vial 32 can be controlled by the length of time the manual valve actuator button 31 is depressed. Typically, it is expected that 5 or 10 cc's of the liquid from container 12 will be delivered to vial 32 whereupon the drug containing vial 32 with the 10 cc's of liquid will be agitated for a time sufficient to suspend the previously dry medicine. It will be appreciated, that certain medicines already come in a liquid form in similar vials. In such a case, the liquid medicine may be administered to the patient without performing this initial dilution and agitation step.
Once the medicine in the vial 32 is in a liquid form, the vial 32 and valved adaptor 26 are inverted to the position shown in FIG. 4. The valved adaptor 26 of the present invention is so constructed such that when moved to a position such that the drug vial 32 is inverted, liquid from the container 12 passing through drip chamber 14 enters the vial through short tubing segment 27 and exits from the vial through short tubing segment 28, the rate of delivery of the liquid being maintained by clamp 23 in the usual fashion. In this way, the contents of the primary I.V. administration container 12 washes through vial 32 to effect delivery of the totallity of the drug contained within the vial to the patient.
The valved adaptor 26 can be formed in any of several configurations. A first configuration for such an adaptor is shown in section in FIGS. 5 and 6. FIG. 5 illustrates the adaptor 26 in the upright position as illustrated in FIGS. 1-3, while FIG. 6 shows the adaptor 26 in the inverted drug delivery position as illustrated in FIG. 4. The adaptor 26 includes an entry port 33 to which the short tubing segment 27 is attached and an exit port 34 to which short tubing segment 28 is attached. In the position shown in FIG. 5, fluid entering valve 26 through entry port 33 passes into a first conical valve chamber 35 which is closed by ball 36 which prevents the fluid from passing downward any further and instead causes the fluid to pass upward into conical valve chamber 37 which contains ball 38 shown in an open position. The fluid passes through valve chamber 37 upwardly out exit port 34. The valve 26 thus acts to direct fluid from the short tubing segment 27 to the short tubing segment 28 and bypass the rest of the valve structure.
The spike 29 of valve 26 shown in FIG. 5 is seen to include a central inlet port 39 including a sharpened lower edge 40 to permit easy insertion of the spike through the rubber stopper of vial 32. Two additional ports 41 and 42 are provided on opposite sides of the central port and have a tapered lower edge 43 which permits the spike to be inserted in the rubber stopper to a point where all three ports 39, 41 and 42 communicate with the interior of the vial 32 when the vial is situated as shown in FIG. 3. To dilute the contents of the drug containing vial 32, one manually actuates push button 31 causing the walls of conical valve chamber 35 to deform from their circular cross section to an oval cross section whereby fluid entering entry port 33 may pass by ball 36 down into the vial 32 through the central opening 39 in spike 29. As the fluid enters the vial through central opening 39, air is permitted to exit from the vial 32 through valve chamber 44, past ball 45 which is gravitationally situated in an open position, and out an air pervious liquid barrier situated in aperture 46. Material for forming such an air pervious liquid barrier is conventionally available and comprises a fluro plastic material sold by the Fluro Techniques Corporation under their designation M8A2000. The ball valves 47 and 49 act to prevent air from entering the primary I.V. system when the valve is in its upright position as shown in FIG. 5. When the push button 31 is released, the walls of the valve chamber 35 resume their circular cross section and are sealed by ball 36 to prevent any further entry of fluid into vial 32. The drug containing vial 32 having the desired amount of liquid therein can then be agitated to suspend or dissolve the medication in the liquid.
The valve 26 and vial 32 are then inverted from the position shown in FIGS. 3 and 5 to the drug delivery position shown in FIGS. 4 and 6. In this position, fluid from container 12 enters entry port 33 through the short segment of tubing 27 to valve chamber 35 which is now open by virtue of ball 36 being gravitationally disengaged from the conical surface of chamber 35. Additionally, ball 38 is now seated in conical valve chamber 37 so as to prevent any bypass of fluid to the outlet port 34. Instead, the fluid entering inlet port 33 is directed upward through central opening 39 in spike 29 and into the drug containing vial 32. The ball 45 is seated in chamber 44 so as to prevent the exit of any material through opening 42 to port 46. Rather, the fluid contents of vial 32 flows into exit port 41 and passes through open valves 47 and 49 containing balls 48 and 50 respectively to exit port 34 where the drug containing fluid now enters tubular member 28. When the valved adaptor 26 is in the inverted position shown in FIG. 6, fluid from the container 12 is directed continuously in inlet port 33 through valve 35 and central port 39 of spike 29 to the drug containing vial 32 whereupon the contents of the vial are emptied out through exit port 41 through valves 47 and 49 and finally out exit port 34. The contents of the drug vial 32 is thus continuously washed by the contents of the primary I.V. container 12 until all remaining traces of the drug within the vial 32 are removed and delivered to the patient.
Another gravitationally operated valved adaptor 26 in accordance with the present invention is shown in FIGS. 7 and 8 having entry port 33 and exit port 34 connected to the short lengths of tubing 27 and 28 respectively. Liquid from the container 12 entering the entry port 33 of valve 26 in its upright position as shown in FIG. 7 is prevented from descending to the drug vial by means of ball 51 sealing conical valve chamber 52. The liquid is thus directed upwardly into valve chamber 53 past ball 54. The liquid is prevented from travelling further due to ball 64 sealing valve chamber 65 and hence the liquid exits through exit conduit 34. In this position, the fluid bypasses any contact with the remaining portion of the valved adaptor 26.
The valved adaptor 26 shown in FIG. 7 includes a spike 29 having an entry passageway 57 which descends to the lower end 58 of spike 29 and a shorter exit passageway 59 which terminates at a point sufficiently near the upper end of spike 29 as to permit the minimum penetration through a rubber stopper of a conventional drug containing vial. To dilute the contents of the drug containing vial, button 60 is manually actuated which deforms the wall of valve chamber 52 from its circular cross section to a more oval cross section thereby admitting fluid from entry port 32 past ball 51 down entry port 57 into the drug containing vial 32. Simultaneous with the entry of the fluid past ball 51, air is permitted to exit from the vial through exit port 59 past ball 61 in valve chamber 62 and out aperture 63 which is again sealed by an air pervious liquid barrier as previously described in connection with FIGS. 5 and 6. While the air can exit through opening 63, it is unable to pass through to exit port 34 due to the presence of ball 55 sealing valve chamber 56.
When the desired amount of fluid enters the drug containing vial 32 and the vial is sufficiently agitated to dissolve and resuspend the drug within the vial, the vial 32 and valved adaptor 26 are again inverted as shown in FIGS. 4 and 8 which causes the balls 51, 54, 55, 61, and 64 to move within their respective chambers from the position shown in FIG. 7 to that shown in FIG. 8. Thus, ball 54 closes valve chamber 53 thereby preventing the fluid entering entry port 33 from bypassing the remaining portion of the valved adaptor 26. Instead, the fluid enters the now open valve chamber 52 by-passing ball 51 and proceeds upwardly through the elongated entry port 57 of spike 29 into the drug containing vial 32. The fluidized contents of the drug containing vial 32 enters the exit port 59 and proceeds downwardly to valve chamber 62 but is prevented from exiting out port 63 by means of ball 61 closing valve chamber 62. Instead, the fluid passes through branch 66 into valve chamber 65 past open ball 64 into valve chamber 56 past open ball 55 and out exit port 34. While FIGS. 5 through 8 illustrate two embodiments of the gravitationally actuated valved adaptor 26 in accordance with the present invention, other similarly functioning devices may be constructed which fulfill the objectives of the present invention to serially connect a drug containing vial to the delivery tube of a primary intravenous administration set.
FIGS. 9 through 11 illustrate yet another embodiment of the present invention in which the valved adaptor 26 includes a reciprocating spool valve 70 within a valve body 71. The body 71 includes entry port 33 and an exit port 34 which are connected to the short lengths of tubing 27 and 28 respectively. The spool valve 70 is biased toward the position shown in FIG. 9 by a spring biasing means 72 and is actuable against the spring bias by a pressure exerted on end push button 73. In the fully biased position shown in FIG. 9, fluid entering the entry port 33 is caused to flow through channel 74, central spool opening 75, and channel 76 to exit port 34. The central spool opening 75 does not communicate with any other portion of the valve and thus the fluid entering entry port 34 bypasses the remaining structure of the valved adaptor 26 and exits out exit port 34.
The push button 73 on the spool valve is manually actuable to a first position shown in FIG. 10 such that the extremity of the push button 73 is flush with the right surface 77 of valve body 71. In this position, fluid entering the entry port 33 descends directly into the central spool opening 75 while channel 76 is blocked thus preventing the fluid from exiting out exit port 34. Instead, the fluid is directed down the entry port 78 of spike 29 into a drug containing vial 32 attached in a manner as shown in FIG. 3. As the fluid enters the vial 32 through entry port 78 in spike 29, air is permitted to escape from the drug containing vial through exit port 79 and aperture 80 in the spool valve which aperture leads thru the end of the valve opposite the push button 73 to an opening 81 having an air pervious liquid barrier 82 situated therein. In this manner, the drug in the drug containing vial can be diluted from fluid in the primary I.V. container 12 to the required amount. The drug containing vial is then agitated until the drug therein is resuspended or dissolved in the liquid and ready for administration to the patient.
When the drug is ready for administration to the patient, the drug containing vial 32 and valved adaptor 26 are inverted in a holder having an automatic actuation means 83 shown in FIG. 11 which depresses the spool valve 70 against the biasing means 72 to a position even further than that shown in FIG. 10 such that the push button 73 is now flush with the bottom of slot 84 cut in the end of valve body 71. In this position, fluid entering entry port 33 enters the central spool opening 75 and through the entry port 78 in spike 29 to the interior of the drug containing vial 32. Fluid from within the vial 32 exits through opening 79 in spike 29 and is directed by a secondary spool slot 85 to exit port 34 and thence to the short tubing segment 28. The position of the spool valve 70 within valve body 71 is determined by either the manual actuation as shown in FIG. 10 or the mechanical actuation as shown in FIG. 11 against the biasing force provided by spring biasing means 72. Thus, after the interior of the vial has been washed for a period of time from fluid from the primary I.V. container 12 and all the drug originally contained therein has been administered to the patient, the valve may be returned from the position shown in FIG. 11 to that shown in FIG. 9 and the vial 32 removed from spike 29.
FIG. 12 shows an alternative embodiment for a valve adaptor 26 in accordance with the present invention which functions in a manner somewhat similar to that illustrated in FIGS. 9 through 11. In FIG. 12, the spool valve is divided into a right spool 70a and a left spool 70b which are separated by a spring biasing means 72 wholly contained within the central spool opening 75. The valve adaptor 26 is shown in FIG. 12 in bypass situation analogous to that shown in FIG. 9. The depression of spool element 70a by a pressure on end 73 causes the contents of the vial 32 to be diluted in a manner similar to that shown in FIG. 10. The delivery of the contents of the drug containing vial to the patient is effected by the inversion of the vial 32 and valved adaptor 26 along with the simultaneous depression of button 73 on spool element 70a and button 86 on spool element 70b so as to cause the appropriate flow from the entry port 33 down through spike 29 and back out exit port 34. Still other variations of the basic invention employing a reciprocating spool valve may be possible for achieving the intended function of serially connecting a drug containing vial in the delivery tube of a primary intravenous administration set.
FIGS. 13-16 show yet another embodiment for a valved adaptor 26 in accordance with the present invention. The valved adaptor 26 is connected to the lower end 18 of drip chamber 14 by a short segment of flexible tubing 27 connected to entry port 33 of the valved adaptor 26. The adaptor 26 includes a body 90 having a radial platelike extension 91 having an upstanding locking collar extending around approximately 270 degrees of the plate. A drug containing vial 32 can be impaled on the spike 29 when the spike is in the far left position shown in phantom in FIG. 13. Thereafter, the spike and container can be rotated about an axis perpendicular to the plane of FIG. 13 and the locking collar 92 will act to capture the sealing ring 93 on the vial 32 and hence the vial itself.
When the spike 29 is in the position shown in phantom in FIG. 13, the spool valve 94 within the valve body 90 is in the position shown in FIG. 14. In this position, fluid from the primary intravenous administration set container 12 enters the entry port 33 and is directed by means of channel 95 directly to exit port 34 which is connected to the output tube 28. In this position, the intravenous fluid from container 12 completely bypasses the remainder of the valve system.
After a drug containing vial 32 is impaled on the spike 29, the contents of the vial 32 may be diluted by rotating the spike to a downwardly directed position as shown in FIG. 15. In this position, fluid entering entry port 33 is directed by channel 96 to inlet port 97 in spike 29. Simultaneously, air is permitted to exit from the vial 32 through exit port 98 in spike 29 past one-way valve 99 which opens to the atmosphere. After the desired amount of fluid enters into the drug containing vial, the vial 32 and spike 29 are rotated to a position opposite that shown in phantom in FIG. 13 and the contents agitated until the drug is suspended or dissolved in the liquid within the vial.
At such time as the drug is ready for administration to the patient, the vial and spike are rotated to an inverted position shown in FIG. 16. In this position, fluid entering the entry port is directed immediately to the inlet port 97 of spike 29 and thus into the interior of the drug containing vial 32. The contents of the vial exits directly through exit port 98 of spike 29 and out the exit port 34. The apparatus is left in this position until such time as the drugs within the vial 32 have been fully dispensed to the patient whereupon the vial 32 and spike 29 are rotated back to the phantom position illustrated in FIG. 13 and the drug vial 32 removed from the valved adaptor 26. While FIGS. 13 through 16 illustrate one possible configuration for a rotating spool valve fulfilling the objectives of the present invention, other configurations may be possible which would act to serially connect a drug containing vial in the delivery tube of a primary intravenous administration set in accordance with the objectives of this invention.
Although the invention has been described in detail with reference to certain preferred embodiments, other variations and modifications exit within the scope and spirit of the invention as described and as defined in the following claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2573576 *||Sep 14, 1948||Oct 30, 1951||Culligan Zeolite Company||Chemical feeder|
|US2848996 *||Nov 8, 1956||Aug 26, 1958||Gordon E Eckley||Syringe|
|US3128917 *||Apr 14, 1964||krause|
|US3678959 *||Jul 30, 1970||Jul 25, 1972||Richard B Liposky||Hand operable selector valve|
|US3857392 *||Nov 1, 1972||Dec 31, 1974||Ims Ltd||Intravenous container with dislodgeable septum and dislodging piercer|
|US3889687 *||Jan 31, 1974||Jun 17, 1975||Hakim Salomon||Shunt system for the transport of cerebrospinal fluid|
|US3931818 *||Jul 22, 1974||Jan 13, 1976||Michael Goldowsky||Liquid administration apparatus|
|US4047527 *||Nov 21, 1975||Sep 13, 1977||Kelsen Arthur F||Oral syringe|
|US4068681 *||Oct 10, 1975||Jan 17, 1978||Hydro Mix, Inc.||Liquid proportioning device|
|US4141379 *||May 16, 1977||Feb 27, 1979||Cutter Laboratories, Inc.||Check valve|
|US4237880 *||Feb 28, 1979||Dec 9, 1980||Abbott Laboratories||Equipment sets for the sequential administration of medical liquids at dual flow rates employing a combined air barrier and liquid sequencing valve controlled by a common flexible membrane|
|US4252116 *||Feb 28, 1979||Feb 24, 1981||Abbott Laboratories||Equipment sets having a novel flexible diaphragm valve in a secondary liquid flow path for the sequential administration of medical liquids at dual flow rates|
|US4258712 *||Feb 28, 1979||Mar 31, 1981||Abbott Laboratories||Equipment sets having a pilot liquid controlled primary tube valve for the sequential administration of medical liquids at dual flow rates|
|US4269213 *||Jun 6, 1979||May 26, 1981||Nissan Motor Company, Limited||Safety valve|
|US4332247 *||Jul 21, 1980||Jun 1, 1982||Baxter Travenol Laboratories, Inc.||Administration set including burette with pivotable air valve|
|US4392850 *||Nov 23, 1981||Jul 12, 1983||Abbott Laboratories||In-line transfer unit|
|US4392851 *||Nov 23, 1981||Jul 12, 1983||Abbott Laboratories||In-line transfer unit|
|US4397335 *||May 26, 1981||Aug 9, 1983||Doblar Dennis D||Rotary valve especially useful in a medical system including a flow-directed venous catheter|
|US4424056 *||Nov 27, 1981||Jan 3, 1984||Alza Corporation||Parenteral administration|
|US4465471 *||Jul 26, 1982||Aug 14, 1984||Eli Lilly And Company||Intravenous administration system for dry medicine|
|FR1122616A *||Title not available|
|GB275821A *||Title not available|
|GB1461161A *||Title not available|
|GB2083141A *||Title not available|
|WO1981001241A1 *||Oct 9, 1980||May 14, 1981||Baxter Travenol Lab||System for the sterile mixing of materials|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4573967 *||Dec 6, 1983||Mar 4, 1986||Eli Lilly And Company||Vacuum vial infusion system|
|US4735608 *||May 14, 1986||Apr 5, 1988||Del F. Kahan||Apparatus for storing and reconstituting antibiotics with intravenous fluids|
|US4804366 *||Oct 29, 1987||Feb 14, 1989||Baxter International Inc.||Cartridge and adapter for introducing a beneficial agent into an intravenous delivery system|
|US4832690 *||Jan 23, 1987||May 23, 1989||Baxter International Inc.||Needle-pierceable cartridge for drug delivery|
|US4850978 *||Oct 29, 1987||Jul 25, 1989||Baxter International Inc.||Drug delivery cartridge with protective cover|
|US4856567 *||Jul 22, 1987||Aug 15, 1989||Sicim Spa||Loader-mixer device for endermic injectors|
|US4874366 *||Dec 19, 1988||Oct 17, 1989||Baxter Internatiional Inc.||Housing enabling passive mixing of a beneficial agent with a diluent|
|US4888008 *||Aug 30, 1988||Dec 19, 1989||Sherwood Medical Company||Vented spike connection component|
|US4997429 *||Dec 28, 1988||Mar 5, 1991||Sherwood Medical Company||Enteral bottle cap with vent valve|
|US5024657 *||May 4, 1990||Jun 18, 1991||Baxter International Inc.||Drug delivery apparatus and method preventing local and systemic toxicity|
|US5030203 *||Nov 16, 1987||Jul 9, 1991||Baxter International Inc.||Ampule for controlled administration of beneficial agent|
|US5041105 *||Oct 29, 1990||Aug 20, 1991||Sherwood Medical Company||Vented spike connection component|
|US5074844 *||Oct 19, 1988||Dec 24, 1991||Baxter International Inc.||Passive drug delivery system|
|US5116316 *||Feb 25, 1991||May 26, 1992||Baxter International Inc.||Automatic in-line reconstitution system|
|US5147333 *||May 13, 1991||Sep 15, 1992||Burron Medical Inc.||Needleless injection port with automatic backcheck valve|
|US5156598 *||Aug 19, 1991||Oct 20, 1992||C. R. Bard, Inc.||Prefilled syringe delivery system|
|US5201705 *||Jul 6, 1987||Apr 13, 1993||Aktiebolaget Hassle||Device for release of a substance|
|US5224929 *||Dec 21, 1990||Jul 6, 1993||C. R. Bard, Inc.||Irrigation/aspiration cannula and valve assembly|
|US5391163 *||Jan 31, 1992||Feb 21, 1995||Inpaco Corporation||Pouch for administering medical fluids|
|US5720722 *||Jan 11, 1996||Feb 24, 1998||Medela, Incorporated||Connector for use in single and double breast pumping and breast pump using same|
|US5957898||May 20, 1998||Sep 28, 1999||Baxter International Inc.||Needleless connector|
|US5989237 *||Dec 4, 1997||Nov 23, 1999||Baxter International Inc.||Sliding reconstitution device with seal|
|US6019750 *||Dec 4, 1997||Feb 1, 2000||Baxter International Inc.||Sliding reconstitution device with seal|
|US6022339 *||Sep 15, 1998||Feb 8, 2000||Baxter International Inc.||Sliding reconstitution device for a diluent container|
|US6039302 *||Sep 13, 1999||Mar 21, 2000||Nypro Inc.||Swabbable luer-activated valve|
|US6063068 *||Sep 15, 1998||May 16, 2000||Baxter International Inc.||Vial connecting device for a sliding reconstitution device with seal|
|US6070761 *||Aug 22, 1997||Jun 6, 2000||Deka Products Limited Partnership||Vial loading method and apparatus for intelligent admixture and delivery of intravenous drugs|
|US6071270 *||Dec 4, 1997||Jun 6, 2000||Baxter International Inc.||Sliding reconstitution device with seal|
|US6090091 *||Sep 15, 1998||Jul 18, 2000||Baxter International Inc.||Septum for a sliding reconstitution device with seal|
|US6090092 *||Dec 4, 1997||Jul 18, 2000||Baxter International Inc.||Sliding reconstitution device with seal|
|US6113583 *||Sep 15, 1998||Sep 5, 2000||Baxter International Inc.||Vial connecting device for a sliding reconstitution device for a diluent container|
|US6159192 *||Dec 4, 1997||Dec 12, 2000||Fowles; Thomas A.||Sliding reconstitution device with seal|
|US6261282||May 20, 1998||Jul 17, 2001||Baxter International Inc.||Needleless connector|
|US6344033||Aug 9, 1999||Feb 5, 2002||Baxter International, Inc.||Needleless connector|
|US6360784 *||Dec 22, 1999||Mar 26, 2002||Medtronic, Inc.||Valved connector and method of use|
|US6530907||Aug 5, 1998||Mar 11, 2003||Sugan Co., Ltd.||Channel switching apparatus|
|US6582415||May 2, 2000||Jun 24, 2003||Thomas A. Fowles||Sliding reconstitution device for a diluent container|
|US6610040||May 8, 2000||Aug 26, 2003||Baxter International Inc.||Sliding reconstitution device with seal|
|US6652488||Sep 11, 2000||Nov 25, 2003||Stryker Corporation||Surgical suction irrigator|
|US6669681||Jul 11, 2001||Dec 30, 2003||Baxter International Inc.||Needleless connector|
|US6719719 *||May 23, 2001||Apr 13, 2004||Elan Pharma International Limited||Spike for liquid transfer device, liquid transfer device including spike, and method of transferring liquids using the same|
|US6746419||Dec 14, 1999||Jun 8, 2004||Stryker Corporation||Irrigation handpiece with built in pulsing pump|
|US6755391||Oct 22, 2001||Jun 29, 2004||Nypro Inc.||Anti-drawback medical valve|
|US6852103||Jan 16, 2003||Feb 8, 2005||Baxter International Inc.||Sliding reconstitution device with seal|
|US6869426||Nov 7, 2002||Mar 22, 2005||Nypro Inc.||Anti-drawback medical valve|
|US6875203||May 3, 2000||Apr 5, 2005||Thomas A. Fowles||Vial connecting device for a sliding reconstitution device for a diluent container|
|US6883778||Jan 6, 2000||Apr 26, 2005||Nypro Inc.||Apparatus for reducing fluid drawback through a medical valve|
|US6890328||Apr 17, 2003||May 10, 2005||Baxter International Inc.||Sliding reconstitution device for a diluent container|
|US7014169||May 13, 2004||Mar 21, 2006||Nypro Inc.||Anti-drawback medical valve|
|US7074216||Mar 26, 2002||Jul 11, 2006||Baxter International Inc.||Sliding reconstitution device for a diluent container|
|US7080672||Aug 22, 2002||Jul 25, 2006||Sherwood Services Ag||Sliding seal adapter for a feeding system|
|US7100890||Mar 16, 2001||Sep 5, 2006||Nypro Inc.||Swabbable luer-activated valve|
|US7137974 *||Jul 24, 2003||Nov 21, 2006||Almasian Joseph M||Sterile connector|
|US7226423||Oct 22, 2004||Jun 5, 2007||Goldenberg Alec S||Aspiration needle with venting feature|
|US7357792||Oct 16, 2003||Apr 15, 2008||Nypro Inc.||Positive push medical valve with internal seal|
|US7358505||Dec 23, 2003||Apr 15, 2008||Baxter International Inc.||Apparatus for fabricating a reconstitution assembly|
|US7396348||Aug 20, 2002||Jul 8, 2008||Nypro Inc.||Medical valve with expandable member|
|US7425209||Dec 23, 2003||Sep 16, 2008||Baxter International Inc.||Sliding reconstitution device for a diluent container|
|US7473246 *||Jun 22, 2006||Jan 6, 2009||Baxter International Inc.||Medicant reconstitution container and system|
|US7641851||Jan 5, 2010||Baxter International Inc.||Method and apparatus for validation of sterilization process|
|US7662135 *||Feb 16, 2010||Byron Cris Bauer||Methods and apparatus for controlling intravenous fluid flow to a patient|
|US7753892||Jul 13, 2010||Nypro Inc.||Anti-drawback medical valve|
|US7789864||Nov 3, 2003||Sep 7, 2010||Nypro Inc.||Luer-activated valve|
|US7794436 *||Jun 12, 2004||Sep 14, 2010||Lloyd Jay Pinel||Controlled gastric bolus feeding device|
|US7837658||Nov 23, 2010||Nypro Inc.||Anti-drawback medical valve|
|US7887519||Jan 10, 2006||Feb 15, 2011||Nypro Inc.||Valve with internal lifter|
|US7914502||Jul 21, 2004||Mar 29, 2011||Nypro Inc.||Anti-drawback medical valve|
|US8022375||Sep 20, 2011||Baxter International Inc.||Method and apparatus for validation of sterilization|
|US8226627||Jul 24, 2012||Baxter International Inc.||Reconstitution assembly, locking device and method for a diluent container|
|US8316898||May 4, 2008||Nov 27, 2012||Medimop Medical Projects Ltd.||Automatic liquid drug preparation apparatus for the preparation of a predetermined dosage of liquid drug|
|US8506548 *||Nov 13, 2009||Aug 13, 2013||Jms Co., Ltd.||Connector|
|US8556879||Nov 13, 2009||Oct 15, 2013||Jms Co., Ltd.||Connector|
|US8568371||Jun 21, 2010||Oct 29, 2013||Np Medical Inc.||Medical valve with improved back-pressure sealing|
|US8597232||Dec 22, 2010||Dec 3, 2013||Medimop Medical Projects, Ltd.||Medical apparatus and single use kit including linear flow control device for use therewith for reconstitution and administration of liquid drug dosage|
|US8701696||Jun 10, 2010||Apr 22, 2014||Industrie Borla S.P.A.||Device for the controlled supply of a liquid to a medical flow line|
|US8827977||Nov 1, 2011||Sep 9, 2014||Icu Medical, Inc.||Vial adaptors and methods for regulating pressure|
|US8876784||Nov 22, 2010||Nov 4, 2014||Np Medical Inc.||Anti-drawback medical valve|
|US8882738||Feb 15, 2012||Nov 11, 2014||Icu Medical, Inc.||Locking vial adaptors and methods|
|US8945084||Sep 30, 2011||Feb 3, 2015||Icu Medical, Inc.||Pressure-regulating vial adaptors and methods|
|US8974433||Apr 13, 2011||Mar 10, 2015||Icu Medical, Inc.||Pressure-regulating vials and containers|
|US8992501||Jul 30, 2012||Mar 31, 2015||Icu Medical, Inc.||Pressure-regulating vial adaptors and methods|
|US9005179||Jun 22, 2012||Apr 14, 2015||Icu Medical, Inc.||Pressure-regulating apparatus for withdrawing medicinal fluid from a vial|
|US9005180||Sep 30, 2011||Apr 14, 2015||Icu Medical, Inc.||Vial adaptors and methods for regulating pressure|
|US9060921||Mar 6, 2012||Jun 23, 2015||Icu Medical, Inc.||Air-filtering vial adaptors and methods|
|US9072657||Sep 30, 2011||Jul 7, 2015||Icu Medical, Inc.||Pressure-regulating vial adaptors and methods|
|US9089475||Jan 22, 2014||Jul 28, 2015||Icu Medical, Inc.||Pressure-regulating vial adaptors|
|US9107808||Sep 20, 2013||Aug 18, 2015||Icu Medical, Inc.||Adaptors for removing medicinal fluids from a container|
|US9132062||Feb 12, 2014||Sep 15, 2015||Icu Medical, Inc.||Pressure-regulating vial adaptors|
|US9138572||Jun 24, 2010||Sep 22, 2015||Np Medical Inc.||Medical valve with fluid volume alteration|
|US9237986 *||Mar 14, 2013||Jan 19, 2016||Carefusion 303, Inc.||Vial access cap and syringe with gravity-assisted valve|
|US9259565||Sep 30, 2013||Feb 16, 2016||Np Medical Inc.||Medical valve with improved back-pressure sealing|
|US9345643 *||Apr 26, 2013||May 24, 2016||Jms Co., Ltd.||Medical connector|
|US9351905||Mar 28, 2013||May 31, 2016||Icu Medical, Inc.||Anti-reflux vial adaptors|
|US20030050610 *||Aug 20, 2002||Mar 13, 2003||Newton Brian L.||Medical valve with expandable member|
|US20030093061 *||Nov 7, 2002||May 15, 2003||Ganem Charles F.||Anti-drawback medical valve|
|US20040068237 *||Oct 3, 2002||Apr 8, 2004||Bauer Byron Cris||Methods and apparatus for controlling intravenous fluid flow to a patient|
|US20040133171 *||Oct 16, 2003||Jul 8, 2004||Newton Brian L.||Positive push medical valve with internal seal|
|US20040206924 *||May 13, 2004||Oct 21, 2004||Newton Brian L.||Anti-drawback medical valve|
|US20040211484 *||May 24, 2004||Oct 28, 2004||Sherwood Services, Ag.||Sliding seal adapter for a feeding system|
|US20050090797 *||Jul 24, 2003||Apr 28, 2005||Almasian Joseph M.||Sterile connector|
|US20050154357 *||Jun 12, 2004||Jul 14, 2005||Pinel Lloyd J.||Controlled gastric bolus feeding device|
|US20060089567 *||Oct 22, 2004||Apr 27, 2006||Goldenberg Alec S||Aspiration needle with venting feature|
|US20070083156 *||Oct 6, 2005||Apr 12, 2007||Atrium Medical Corporation||Subcutaneous needle connection system|
|US20070142743 *||Dec 16, 2005||Jun 21, 2007||Provencher Kevin M||Tissue sample needle actuator system and apparatus and method of using same|
|US20070142744 *||Dec 16, 2005||Jun 21, 2007||Provencher Kevin M||Tissue sample needle and method of using same|
|US20070299419 *||Jun 22, 2006||Dec 27, 2007||Vancaillie Joost M||Medicant reconstitution container and system|
|US20080249499 *||Jun 11, 2008||Oct 9, 2008||Baxter International Inc.||Medicant delivery system|
|US20090270832 *||Apr 23, 2008||Oct 29, 2009||Baxter International Inc.||Needleless port assembly for a container|
|US20100087786 *||May 4, 2008||Apr 8, 2010||Medimop Medical Projects Ltd.||Automatic Liquid Drug Preparation Apparatus for the Preparation of a Predetermined Dosage of Liquid Drug|
|US20110175347 *||Nov 13, 2009||Jul 21, 2011||Jms Co., Ltd.||Connector|
|US20110178493 *||Nov 13, 2009||Jul 21, 2011||Jms Co., Ltd.||Connector|
|US20110190723 *||Aug 4, 2011||Fangrow Thomas F||Pressure-regulating vials and containers|
|US20120328219 *||Aug 10, 2011||Dec 27, 2012||Miura Co., Ltd.||Medicine package|
|US20140221973 *||Apr 9, 2014||Aug 7, 2014||Carefusion 303, Inc.||Intravenous piston pump disposable and mechanism|
|US20140261876 *||Mar 14, 2013||Sep 18, 2014||George Michel Mansour||Vial access cap and syringe with gravity-assisted valve|
|US20150083950 *||Apr 26, 2013||Mar 26, 2015||Jms Co., Ltd.||Medical connector|
|USRE43142||Jan 24, 2012||Baxter International, Inc.||Needleless connector|
|CN100531812C||Aug 22, 2002||Aug 26, 2009||舍伍德服务公开股份有限公司||Sliding seal adapter for a feeding system|
|CN102655837A *||Dec 22, 2010||Sep 5, 2012||麦迪麦珀医疗工程有限公司||Medical apparatus and single use kit including flow control device for use therewith for reconstitution and administration of liquid drug dosage|
|CN102655837B||Dec 22, 2010||Aug 20, 2014||麦迪麦珀医疗工程有限公司||Medical apparatus and single use kit including flow control device for use therewith for reconstitution and administration of liquid drug dosage|
|CN102802696A *||Jun 10, 2010||Nov 28, 2012||伯尔拉工业有限公司||Device for the controlled supply of a liquid to a medical flow line|
|EP0246715A2 *||Nov 29, 1985||Nov 25, 1987||BAXTER INTERNATIONAL INC. (a Delaware corporation)||Apparatus for the safe delivery of a beneficial agent to a patient|
|EP0252892A1 *||Jul 6, 1987||Jan 13, 1988||Aktiebolaget Hässle||A device for release of a substance|
|EP0521460A1 *||Jun 30, 1992||Jan 7, 1993||Axel von Brand||Transfer and withdrawal spike|
|EP0576380A1 *||Jun 25, 1993||Dec 29, 1993||Laboratoire Aguettant||Sterile connection system|
|EP0639389A1 *||Aug 12, 1994||Feb 22, 1995||Franz A. Dieringer||Connector for joining flexible tubing|
|EP0960628A1 *||Sep 4, 1996||Dec 1, 1999||Baker, Michiko||Syringe serving also as an ampule and syringe for collecting blood|
|EP1091164A1 *||Aug 5, 1998||Apr 11, 2001||Sugan Co., Ltd.||Channel switching apparatus|
|EP1948267A2 *||Nov 3, 2006||Jul 30, 2008||Patton Medical Devices, LP.||Fluid delivery devices, systems and methods|
|WO1987007159A1 *||May 28, 1987||Dec 3, 1987||Baxter Travenol Laboratories, Inc.||Passive drug delivery system|
|WO1987007160A1 *||May 28, 1987||Dec 3, 1987||Baxter Travenol Laboratories, Inc.||Drug delivery apparatus with piston injection site|
|WO1988000476A1 *||Jul 6, 1987||Jan 28, 1988||Aktiebolaget Hässle||A device for release of a substance|
|WO1988005318A1 *||Jan 19, 1988||Jul 28, 1988||Baxter Travenol Laboratories, Inc.||Needle-pierceable cartridge for drug delivery|
|WO1989003703A1 *||Oct 24, 1988||May 5, 1989||Baxter International Inc.||Drug delivery cartridge with protective cover|
|WO1989004190A1 *||Oct 24, 1988||May 18, 1989||Baxter International Inc.||Cartridge and adapter for introducing a beneficial agent into an intravenous delivery system|
|WO2003059415A3 *||Jan 10, 2003||Dec 4, 2003||Milton P Chernack||Method and apparatus for the delivery of contrast fluid to a patient|
|WO2004017852A1 *||Aug 22, 2002||Mar 4, 2004||Sherwood Services, Ag||Sliding seal adapter for a feeding system|
|WO2010146506A1 *||Jun 10, 2010||Dec 23, 2010||Industrie Borla S.P.A.||Device for the controlled supply of a liquid to a medical flow line|
|WO2011077434A1 *||Dec 22, 2010||Jun 30, 2011||Medimop Medical Projects Ltd||Medical apparatus and single use kit including flow control device for use therewith for reconstitution and administration of liquid drug dosage|
|WO2011095766A1 *||Feb 1, 2011||Aug 11, 2011||Imperial Innovations Limited||Manometer and three-way valve|
|WO2013142618A1 *||Mar 20, 2013||Sep 26, 2013||Icu Medical, Inc.||Pressure-regulating vial adaptors|
|U.S. Classification||604/85, 604/84, 604/248, 604/86, 604/411, 604/247, 604/249|
|International Classification||A61M39/22, A61M5/14, A61M5/175|
|Cooperative Classification||A61M39/223, A61M5/1409, A61M5/162|
|European Classification||A61M39/22D, A61M5/14B2|
|Jul 15, 1983||AS||Assignment|
Owner name: ELI LILLY COMPANY, 307 EAST MCCARTY ST., INDIANAPO
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:AKERS, MICHAEL J.;HARGROVE, WILLIAM W.;HARRIS, DALE C.;AND OTHERS;REEL/FRAME:004154/0323
Effective date: 19830714
|Dec 5, 1988||FPAY||Fee payment|
Year of fee payment: 4
|Dec 3, 1992||FPAY||Fee payment|
Year of fee payment: 8
|Mar 18, 1997||REMI||Maintenance fee reminder mailed|
|Aug 10, 1997||LAPS||Lapse for failure to pay maintenance fees|
|Oct 21, 1997||FP||Expired due to failure to pay maintenance fee|
Effective date: 19970813